Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Conmed ( (CNMD) ) just unveiled an announcement.
CONMED Corporation is presenting at the J.P. Morgan Healthcare Conference, highlighting its strategy to boost long-term growth and profitability by evolving its product mix towards higher-margin offerings and expanding market share in key areas like orthopedics and general surgery. The company aims to enhance its industry positioning by delivering above-market revenue growth, driven by innovations in products such as BioBrace and AirSeal, and focusing on operational excellence and environmental, social, and governance initiatives.
More about Conmed
CONMED Corporation operates in the healthcare industry, providing devices and equipment primarily for orthopedic, general surgery, and critical care markets. Their products include surgical visualization systems, orthopedic implants, and minimally invasive surgical instruments, with a focus on increasing market share and profitability in large, attractive markets.
YTD Price Performance: 2.18%
Average Trading Volume: 405,198
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.13B
For detailed information about CNMD stock, go to TipRanks’ Stock Analysis page.
